3.000USD-4.46%Mkt Cap: 228.59M $P/E: —2d ago
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap228.59M $
Enterprise Value306.57M $
Revenue (TTM)155.10M $
Gross Profit72.31M $
Net Income (TTM)-39.00M $
Revenue/Share2.225 USD
Last Price3.000 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees658
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.09
PEG—
EV/EBITDA-15.91
EV/Revenue1.98
P/S1.52
P/B13.21
EPS (TTM)-0.42
EPS (Forward)-0.34
52W Range
0.800073% of range3.800
52W High3.800 USD
52W Low0.8000 USD
Profitability
Gross Margin48.48%
Oper. Margin-3.61%
EBITDA Margin-12.42%
Profit Margin-26.15%
ROE-174.27%
ROA-27.55%
Growth
Revenue Growth9.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.37M $
CapEx (TTM)801.00K $
FCF Margin0.22%
FCF Yield0.15%
Net Debt67.33M $
Net Debt/EBITDA-3.50
Balance Sheet
Debt/Equity4.04
Current Ratio1.88
Quick Ratio1.25
Book Value/Sh0.2340 USD
Cash/Share0.2520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.000 USD
Upside (mean)+100.0%
Target Range5.000 USD – 7.000 USD
$5.000+100.0% to mean$7.000
# Analysts3
Ownership
Shares Out.76.20M
Float34.88M
Insiders30.85%
Institutions54.02%
Short Interest
Short Ratio4.7d
Short % Float27.16%
Short % Out.13.41%
Shares Short9.33M
Short (prev mo.)7.68M
Technical
SMA 501.905 (+57.5%)
SMA 2001.661 (+80.6%)
Beta1.12
S&P 52W Chg18.16%
Avg Vol (30d)3.12M
Avg Vol (10d)4.96M
Technical Indicators
RSI (14)64.5
MACD0.3907
MACD Signal0.3306
MACD Hist.+0.0601
BB Upper3.593 USD
BB Middle2.441 USD
BB Lower1.288 USD
BB Width94.46%
ATR (14)0.2893 USD
Vol Ratio (20d)0.33x